Felix Bachmann

Person

Basel, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical combinations for use in the treatment of neoplastic...
- Patent number 11,419,856
- Issue date Aug 23, 2022
- Basilea Pharmaceutica International AG
- Felix Bachmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of phospho-Akt as a biomarker of drug response
- Patent number 10,724,072
- Issue date Jul 28, 2020
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of glu-tubulin as a biomarker of drug response to furazanobenzi...
- Patent number 10,656,162
- Issue date May 19, 2020
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Grant
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
- Patent number 10,222,377
- Issue date Mar 5, 2019
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of acetylated tubulin as a biomarker of drug response to furaza...
- Patent number 10,067,120
- Issue date Sep 4, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Grant
Use of phospho-Akt as a biomarker of drug response
- Patent number 10,006,078
- Issue date Jun 26, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of glu-tubulin as a biomarker of drug response to furazanobenzi...
- Patent number 9,995,754
- Issue date Jun 12, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
- Patent number 9,970,938
- Issue date May 15, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of acetylated tubulin as a biomarker of drug response to furaza...
- Patent number 9,476,889
- Issue date Oct 25, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of stathmin as a biomarker of drug response to furazanobenzimid...
- Patent number 9,366,682
- Issue date Jun 14, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmun...
- Patent number 8,802,858
- Issue date Aug 12, 2014
- Basilea Pharmaceutica AG
- Jens Pohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aroylfuranes and aroylthiophenes
- Patent number 8,486,996
- Issue date Jul 16, 2013
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenylaminopyridines
- Patent number 8,288,421
- Issue date Oct 16, 2012
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Furazanobenzimidazoles
- Patent number RE42890
- Issue date Nov 1, 2011
- Basilea Pharmaceutica AG
- Martin Eberle
- 548 - Organic compounds
Information Patent Grant
Substituted benzimidazoles and their use for inducing apoptosis
- Patent number 7,951,957
- Issue date May 31, 2011
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfopyrroles
- Patent number 7,612,064
- Issue date Nov 3, 2009
- Takeda Pharmaceutical Company Limited
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted benzimidazoles and their use for inducing apoptosis
- Patent number 7,423,157
- Issue date Sep 9, 2008
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Furazanobenzimidazoles
- Patent number 7,385,061
- Issue date Jun 10, 2008
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metastasis-associated antigen and antibodies thereto
- Patent number 6,713,305
- Issue date Mar 30, 2004
- Novartis AG
- Felix Bachmann
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND...
- Publication number 20220370418
- Publication date Nov 24, 2022
- Basilea Pharmaceutica International AG
- Vassilis GENOUD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...
- Publication number 20220031670
- Publication date Feb 3, 2022
- Basilea Pharmaceutica International AG
- Felix BACHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...
- Publication number 20200390749
- Publication date Dec 17, 2020
- Basilea Pharmaceutica International AG
- Felix BACHMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE
- Publication number 20190010536
- Publication date Jan 10, 2019
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...
- Publication number 20180364254
- Publication date Dec 20, 2018
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE
- Publication number 20180306790
- Publication date Oct 25, 2018
- Basilea Pharmaceutica International AG
- Diane BRAGUER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...
- Publication number 20170122934
- Publication date May 4, 2017
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Publication number 20160320397
- Publication date Nov 3, 2016
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE
- Publication number 20140080872
- Publication date Mar 20, 2014
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Publication number 20140045897
- Publication date Feb 13, 2014
- Heidi Alexandra Lane
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...
- Publication number 20140024686
- Publication date Jan 23, 2014
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...
- Publication number 20140005237
- Publication date Jan 2, 2014
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
USE OF STATHMIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMID...
- Publication number 20130345263
- Publication date Dec 26, 2013
- Basilea Pharmaceutica AG
- Heidi Alexandra Lane
- G01 - MEASURING TESTING
Information Patent Application
FURAZANOBENZIMIDAZOLES AS PRODRUGS TO TREAT NEOPLASTIC OR AUTOIMMUN...
- Publication number 20120264792
- Publication date Oct 18, 2012
- Basilea Pharmaceutica AG
- Jens Pohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Benzimidazoles and their Use for Inducing Apoptosis
- Publication number 20080287681
- Publication date Nov 20, 2008
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenylaminopyridines
- Publication number 20080221171
- Publication date Sep 11, 2008
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted benzimidazoles and their use for inducing apoptosis
- Publication number 20070167505
- Publication date Jul 19, 2007
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted benzimidazoles and their use for inducing apoptosis
- Publication number 20070066670
- Publication date Mar 22, 2007
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sulfopyrroles
- Publication number 20070060570
- Publication date Mar 15, 2007
- Taleda Pharmaceutical Company Limited
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Furazanobenzimidazoles
- Publication number 20070043061
- Publication date Feb 22, 2007
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aroylfuranes and aroylthiophenes
- Publication number 20060205739
- Publication date Sep 14, 2006
- Basilea Pharmaceutica AG
- Martin Eberle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
High throughput screening method for compounds with non-, pro-, or...
- Publication number 20050130237
- Publication date Jun 16, 2005
- Alessandro Strebel
- G01 - MEASURING TESTING

Felix Bachmann

Person

Patents Grantslast 30 patents

Pharmaceutical combinations for use in the treatment of neoplastic...

Use of phospho-Akt as a biomarker of drug response

Use of glu-tubulin as a biomarker of drug response to furazanobenzi...

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Use of acetylated tubulin as a biomarker of drug response to furaza...

Use of phospho-Akt as a biomarker of drug response

Use of glu-tubulin as a biomarker of drug response to furazanobenzi...

Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

Use of acetylated tubulin as a biomarker of drug response to furaza...

Use of stathmin as a biomarker of drug response to furazanobenzimid...

Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmun...

Aroylfuranes and aroylthiophenes

Phenylaminopyridines

Furazanobenzimidazoles

Substituted benzimidazoles and their use for inducing apoptosis

Sulfopyrroles

Substituted benzimidazoles and their use for inducing apoptosis

Furazanobenzimidazoles

Metastasis-associated antigen and antibodies thereto

Patents Applicationslast 30 patents

PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND...

PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...

PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC...

USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE

USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...

USE OF EB1 AS A BIOMARKER OF DRUG RESPONSE

USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE

USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES

USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZI...

USE OF ACETYLATED TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZA...

USE OF STATHMIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMID...

FURAZANOBENZIMIDAZOLES AS PRODRUGS TO TREAT NEOPLASTIC OR AUTOIMMUN...

Substituted Benzimidazoles and their Use for Inducing Apoptosis

Phenylaminopyridines

Substituted benzimidazoles and their use for inducing apoptosis

Substituted benzimidazoles and their use for inducing apoptosis

Sulfopyrroles

Furazanobenzimidazoles

Aroylfuranes and aroylthiophenes

High throughput screening method for compounds with non-, pro-, or...